Live Breaking News & Updates on Stanford Biosecurity
Stay updated with breaking news from Stanford biosecurity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For a predominantly vaccinated adult population with COVID-19, the incidence of hospitalization or emergency department visit is significantly lower for those receiving a single dose of pegylated interferon lambda versus placebo. ....
Washington - A single-injection antiviral treatment for newly infected COVID-19 patients reduced the risk of hospitalization by half in a large-scale cl ....
A single-injection antiviral treatment for newly-infected COVID-19 patients reduced the risk of hospitalization by half in a large-scale clinical trial, according to a study published on Wednesday. Stanford University professor Jeffrey Glenn, coauthor of the study published in the New England Journal of Medicine (NEJM), said the new drug "showed… ....
A single-injection antiviral treatment for newly infected COVID-19 patients reduced the risk of hospitalization by half in a large-scale clinical trial, a study published Wednesday said. Stanford University professor Jeffrey Glenn, co-author of the study published in the New England Journal of Medicine, said the new drug "showed profound benefits for vaccinated and unvaccinated people… ....